Skip to content

REVACLEARRecalls & reported problems across all models

Gambro Renal Products, Inc. · 2 models in the FDA device registry

Data updated Oct 18, 2026 from official FDA records · Editorial policy

3 open recalls name at least one REVACLEAR model. Check whether yours is affected in the recall details, and contact the manufacturer or your healthcare provider.

Adverse event reports
169
Deaths reported
1
Injuries reported
16
Recalls
6

We found 2 models of REVACLEAR by Gambro Renal Products, Inc. in the FDA's device registry (GUDID). Together they are named in 169 adverse event reports in the FDA's MAUDE database, received between Jan 19, 2018 and Apr 4, 2025 — classified as 1 death, 16 injuries, 152 malfunctions.

The most frequently reported specific device problem is “Fluid/Blood Leak” (98 reports).

6 FDA recall records name at least one of these models by its device identifier, 3 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event. Widely used products collect more reports, so totals can't be used to compare products or estimate failure rates. Only reports that name a model's exact device identifier are counted. What reports can and can't tell you · How this data works

Reports received per month, all models

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 1 reportsMar 2024: 1 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 2 reportsJul 2024: 0 reportsAug 2024: 1 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 1 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 1 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

REVACLEAR recalls

FDA recall records that name at least one of these models by its device identifier, newest first. Each recall usually covers specific models or lots, so check the details.

  1. Nov 23, 2022Class IIOpen, Classified

    Reports of Polyurethane Displacement in the dialyzer, and might be identified as a blood leak

    Z-0763-2023 · Root cause: Process control · Recall details · FDA record ↗

  2. Nov 23, 2022Class IIOpen, Classified

    Reports of Polyurethane Displacement in the dialyzer, and might be identified as a blood leak

    Z-0762-2023 · Root cause: Process control · Recall details · FDA record ↗

  3. Nov 23, 2022Class IIOpen, Classified

    Potential for Internal Blood Leaks due to a twisted gasket in the dialyzer

    Z-0760-2023 · Root cause: Process change control · Recall details · FDA record ↗

  4. Nov 15, 2019Class IITerminated

    There is the potential presence of particular matter in the header caps of ten lots the Revaclear 300 Dialyzer.

    Z-1409-2020 · Root cause: Process control · Recall details · FDA record ↗

  5. May 31, 2019Class IITerminated

    There is a potential presence of ruptured dialyzer fibers which may lead to a blood leak during treatment.

    Z-1909-2019 · Root cause: Process control · Recall details · FDA record ↗

  6. May 31, 2019Class IITerminated

    There is a potential presence of ruptured dialyzer fibers which may lead to a blood leak during treatment.

    Z-1908-2019 · Root cause: Process control · Recall details · FDA record ↗

Most reported REVACLEAR problems

Device problems

  • Fluid/Blood Leak98
  • Leak/Splash34
  • Device Contamination with Chemical or Other Material23
  • Adverse Event Without Identified Device or Use Problem12
  • Break4
  • Crack2
  • Connection Problem1
  • Loose or Intermittent Connection1

Patient problems

  • No Consequences Or Impact To Patient78
  • No Clinical Signs, Symptoms or Conditions57
  • No Patient Involvement15
  • Dyspnea5
  • Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available4
  • Hemolysis4
  • Low Blood Pressure/ Hypotension4
  • Hypersensitivity/Allergic reaction2

REVACLEAR models

2 models, most reported first. Each model has its own page with its reports, recalls and device details.

Recent REVACLEAR adverse event reports

The 15 most recent reports across all models, in the reporter's own words as published by the FDA.

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page